{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:54:06Z","timestamp":1793357646558,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000866","name":"Cardiff University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lungcan.2025.108805","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:30:57Z","timestamp":1761550257000},"page":"108805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Delivering equitable access to prehabilitation services to optimise outcomes for patients with lung cancer \u2013 Best practice recommendations from a UK roundtable event"],"prefix":"10.1016","volume":"210","author":[{"given":"William","family":"Ricketts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-9022","authenticated-orcid":false,"given":"Catherine","family":"Sandsund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-7947","authenticated-orcid":false,"given":"Kevin","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asanga","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Dalrymple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Gossage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-5253","authenticated-orcid":false,"given":"Matthew","family":"Evison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108805_b0005","unstructured":"Macmillan. Prehabilitation for people with cancer. Available at: https:\/\/www.macmillan.org.uk\/dfsmedia\/1a6f23537f7f4519bb0cf14c45b2a629\/13225-source\/prehabilitation-for-people-with-cancer (Accessed August 2025)."},{"key":"10.1016\/j.lungcan.2025.108805_b0010","unstructured":"Bloom E. Macmillan Cancer Support Prehabilitation Evidence and Insight Review. 2017. Available from: https:\/\/www.macmillan.org.uk\/_images\/prehabilitation-evidence-and-insight-review_tcm9-335025.pdf (Accessed August 2025)."},{"key":"10.1016\/j.lungcan.2025.108805_b0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12885-023-11254-x","article-title":"Prehabilitation in the lung cancer pathway: a scoping review","volume":"23","author":"Wade-McBane","year":"2023","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2025.108805_b0020","article-title":"Effect of Prehabilitation in Lung Cancer patients Undergoing Lobectomy: a Review","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.lungcan.2025.108805_b0025","article-title":"Preoperative exercise training for people with non-small cell lung cancer (Review)","volume":"9","author":"Granger","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lungcan.2025.108805_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108546","article-title":"Clinical effect of pulmonary rehabilitation during radiotherapy in lung cancer: a randomized controlled trial","volume":"204","author":"Lee","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108805_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108572","article-title":"Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy","author":"Gourlay","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108805_b0040","unstructured":"National Lung Cancer Audit State of the Nation 2025. V2. May 2025."},{"issue":"21","key":"10.1016\/j.lungcan.2025.108805_b0045","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0050","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative Durvalumab for Resectable Non\u2013Small-Cell Lung Cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative Pembrolizumab for Early-Stage Non\u2013Small-Cell Lung Cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0060","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in Resected EGFR-Mutated Non\u2013Small-Cell Lung Cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0065","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa2310532","article-title":"Alectinib in Resected ALK-Positive Non\u2013Small-Cell Lung Cancer","volume":"390","author":"Wu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0070","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.lungcan.2025.108805_b0075","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term results of the SABR-COMET phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108805_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020690","article-title":"Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer","volume":"8","author":"Conibear","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108805_b0085","first-page":"163","article-title":"Recent advances in early-stage lung cancer","volume":"7","author":"Luna","year":"2021","journal-title":"J Clin Transl Res."},{"key":"10.1016\/j.lungcan.2025.108805_b0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/PHM.0b013e31829b4afe","article-title":"Cancer Prehabilitation","volume":"92","author":"Silver","year":"2013","journal-title":"Am. J. Phys. Med. Rehab."},{"key":"10.1016\/j.lungcan.2025.108805_b0090","unstructured":"NHS England. National Optimal Lung Cancer Pathway (NOLCP). Update 2024 Version 4.0."},{"key":"10.1016\/j.lungcan.2025.108805_b0095","year":"2021","journal-title":"Report"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108805_b0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1467-9450.2007.00562.x","article-title":"Regaining a sense of agency and shared self-reliance: the experience of advanced disease cancer patients participating in a multidimensional exercise intervention while undergoing chemotherapy\u2013analysis of patient diaries","volume":"48","author":"Midtgaard","year":"2007","journal-title":"Scand. J. Psychol."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108805_b0110","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1053\/j.jvca.2021.02.049","article-title":"Prehabilitation in Thoracic Cancer Surgery: from Research to Standard of Care","volume":"35","author":"Minnella","year":"2021","journal-title":"J Cardio Vasc Anes."},{"key":"10.1016\/j.lungcan.2025.108805_b0115","unstructured":"Prehab4Cancer. Exercise. Available at: https:\/\/www.prehab4cancer.co.uk\/exercise\/ (Accessed August 2025)."},{"key":"10.1016\/j.lungcan.2025.108805_b0120","first-page":"13","volume":"393","author":"Courneya","year":"2025","journal-title":"Structured Exercise after Adjuvant Chemotherapy for Colon Cancer NEJM."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108805_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/07347332.2013.855963","article-title":"Lung Cancer Stigma, anxiety, Depression and Quality of Life","volume":"32","author":"Brown","year":"2014","journal-title":"J. Psychosoc. Oncol."},{"issue":"2\u20133","key":"10.1016\/j.lungcan.2025.108805_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14740\/wjon1371","article-title":"Quality of Life and Psychological Distress of Lung Cancer patients Undergoing Chemotherapy","volume":"12","author":"Prapa","year":"2021","journal-title":"World J Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108805_b0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clon.2022.08.028","article-title":"Prehabilitation and Rehabilitation for patients with Lung Cancer: a Review of where we are today","volume":"34","author":"Burnett","year":"2022","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108805_b0140","unstructured":"Prehab4Cancer. Wellbeing. Available at: https:\/\/www.prehab4cancer.co.uk\/wellbeing\/ (Accessed August 2025)."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108805_b0145","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajcnut.2024.08.016","article-title":"Effects of high-protein supplementation during cancer therapy: a systematic review and meta-analysis","volume":"120","author":"Orsso","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108805_b0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/j.gastro.2018.05.012","article-title":"Effects of Nutritional Prehabilitation, with and without Exercise, on Outcomes of patients who Undergo Colorectal Surgery: a Systematic Review and Meta-analysis","volume":"155","author":"Gillis","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lungcan.2025.108805_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081164","article-title":"Relative efficacy of prehabilitation interventions and their components: systematic review with network and component network meta-analyses of randomised controlled trials","volume":"388","author":"McIsaac","year":"2025","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.lungcan.2025.108805_b0160","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jamaoncol.2024.4890","article-title":"Survival Outcomes of an Early intervention smoking Cessation Treatment after a Cancer Diagnosis","volume":"10","author":"Cinciripini","year":"2024","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108805_b0165","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7326\/M21-0252","article-title":"Postdiagnosis smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality","volume":"174","author":"Sheikh","year":"2021","journal-title":"Ann Int Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0170","article-title":"Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses (Review)","volume":"2023(9):CD015226","author":"Lindson","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108805_b0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/jamainternmed.2024.7288","article-title":"Smoking Cessation Interventions in the Lung Cancer Screening setting, a Randomized Clinical Trial","volume":"185","author":"Cinciripini","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0180","article-title":"Prehabilitation in patients with advanced stage lung cancer referred for palliative SACT","author":"Jackson","year":"2025","journal-title":"Presented at BTOG"},{"key":"10.1016\/j.lungcan.2025.108805_b0185","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1136\/spcare-2023-004349","article-title":"Early prehabilitation in suspected locally advanced and metastatic lung cancer","volume":"13","author":"Phillips","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.lungcan.2025.108805_b0190","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1016\/j.clon.2024.03.016","article-title":"Early prehabilitation in suspected locally advanced and metastatic lung cancer","volume":"36","author":"Phillips","year":"2024","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108805_b0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13741-020-00145-5","article-title":"Feasibility of setting up a pre-operative optimisation \u2018pre-hab\u2019 service for lung cancer surgery in the UK","volume":"9","author":"Ricketts","year":"2020","journal-title":"Periop Med."},{"key":"10.1016\/j.lungcan.2025.108805_b0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/clinpract12040067","article-title":"Understanding patients\u2019 Experiences and Perspectives of Tele-Prehabilitation: a Qualitative Study to Inform Service Design and delivery","volume":"12","author":"Wu","year":"2022","journal-title":"Clin Pract."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108805_b0205","first-page":"110","volume":"25","author":"Pinsky","year":"2018","journal-title":"False-Positive Screens and Lung Cancer Risk in the National Lung Screening Trial: Implications for Shared Decision-Making J Med Screen."},{"key":"10.1016\/j.lungcan.2025.108805_b0210","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.acra.2020.07.040","article-title":"Factors Influencing the False positive Rate in CT Lung Cancer Screening","volume":"29","author":"Hammer","year":"2022","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.lungcan.2025.108805_b0215","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.surg.2024.08.014","article-title":"No thanks and not for me: a qualitative study of barriers to prehabilitation participation","volume":"176","author":"Clemons","year":"2024","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108805_b0220","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.bja.2022.05.034","article-title":"Feasibility and outcomes of a real-world regional lung cancer prehabilitation programme in the UK","volume":"130","author":"Bradley","year":"2023","journal-title":"Br J Anaes."},{"key":"10.1016\/j.lungcan.2025.108805_b0225","unstructured":"QuestPrehab. Available at: https:\/\/questprehab.com\/ (Accessed August 2025)."},{"key":"10.1016\/j.lungcan.2025.108805_b0230","unstructured":"PrehabRx. About. Available at: https:\/\/www.prehabrx.ca\/#about (Accessed August 2025)."},{"key":"10.1016\/j.lungcan.2025.108805_b0235","unstructured":"NHS England. National Cancer Drugs Fund List v1.371, August 2025."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108805_b0245","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-001021","article-title":"Lung cancer symptoms at diagnosis: results of a nationwide registry study","volume":"5","author":"Ruano-Ravi\u00f1a","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2025.108805_b0250","article-title":"Sedentary Behaviour, Physical activity, and their Associations with Health Outcomes at the Time of Diagnosis in people with Inoperable Lung Cancer","volume":"11(19):5870","author":"Ch\u2019ng SN","year":"2022","journal-title":"J. Clin. Med."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022500697X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022500697X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T04:54:37Z","timestamp":1766033677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950022500697X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"alternative-id":["S016950022500697X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108805","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivering equitable access to prehabilitation services to optimise outcomes for patients with lung cancer \u2013 Best practice recommendations from a UK roundtable event","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108805"}}